In contrast, treatment of PASMC with FGF21 also increased H19 lncRNA; however, in a study by Li et al., increased H19 disrupted the mTOR/ EIF4EBP1 complex, which alleviated pulmonary hypertension [110]. Here, FGF21 is linked to pulmonary arterial hypertension.